Fig. 12
From: CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
C646 treatment inhibited MC38CXCL1+/+ colon cancer tumor progression. a–c Photographs of the tumor after treatment with C646 (MC38 WT, MC38CXCL1−/−, MC38CXCL1+/+). d–f Mean tumor volume after treatment with C646 (MC38 WT, MC38CXCL1−/−, MC38CXCL1+/+). g–i Mean tumor weight after treatment with C646 (MC38 WT, MC38CXCL1−/−, MC38CXCL1+/+). ns no significant, **P < 0.01, ***P < 0.001